How AI Can Help Design Drugs to Treat Opioid Addiction

Summary: Researchers are turning to synthetic intelligence to seek out novel medication that may block kappa opioid receptors with the hope to alleviate opioid habit.

Source: Biophysical Society

Approximately three million Americans endure from opioid use dysfunction, and yearly greater than 80,000 Americans die from overdoses.

Opioid medication, akin to heroin, fentanyl, oxycodone and morphine, activate opioid receptors. Activating mu-opioid receptors results in ache aid and euphoria, but additionally bodily dependence and decreased respiratory, the latter resulting in dying within the case of drug overdose.

Preclinical research have proven that blocking kappa-opioid receptors might supply a promising pharmacological strategy to treating opioid dependence.

By discovering medication that inhibit the kappa-opioid receptor, Leslie Salas Estrada, within the lab of Marta Filizola, on the Icahn School of Medicine at Mount Sinai, hopes to alleviate opioid habit. Salas Estrada, a postdoctoral researcher, will current her work on Monday, February 20 on the 67th Annual Biophysical Society Meeting in San Diego, California.

Kappa-opioid receptors are recognized to mediate mind rewards.

“If you’re addicted and you’re trying to quit, at some point you will get withdrawal symptoms, and those can be really hard to overcome,” Salas Estrada defined, “after a lot of opioid exposure, your brain gets rewired to need more drugs. Blocking the activity of the kappa opioid receptor has been shown in animal models to reduce this need to use drugs in the withdrawal period.”

However, discovering medication that may block the exercise of a protein, such because the kappa-opioid receptor, generally is a lengthy and costly course of. Using computational instruments could make it extra environment friendly, however it may take months to display billions of chemical compounds. Instead, Salas Estrada is utilizing synthetic intelligence (AI) to optimize the method.

This shows the outline of a head — By discovering medication that inhibit the kappa-opioid receptor, Leslie Salas Estrada, within the lab of Marta Filizola, on the Icahn School of Medicine at Mount Sinai, hopes to alleviate opioid habit. Image is within the public area

“Artificial intelligence has the advantage of being able to take huge amounts of information and learn to recognize patterns from it. So, we believe that machine learning can help us to leverage the information that can be derived from large chemical databases to design new drugs from scratch. And in that way, we can potentially reduce the time and costs associated with drug discovery,” she stated.

See additionally

Using details about the kappa-opioid receptor and recognized medication, they educated a pc mannequin to generate compounds which may block the receptor with a reinforcement studying algorithm that rewarded properties which might be favorable for drug therapies.

So far, the workforce has recognized a number of compounds which have promising properties and they’re working with collaborators to synthesize them and ultimately check their potential to dam the kappa-opioid receptor in cells, earlier than testing them in animal fashions for security and effectiveness. Ultimately, Salas Estrada stated, “we hope we can help people struggling with addiction.”